December 8, 2007, Philadelphia, Pa., USA - GlaxoSmithKline plc announced that Eddie Gray, senior vice president and general manager pharmaceuticals UK, will succeed Andrew Witty as president, pharmaceuticals Europe for GlaxoSmithKline, effective January 1, 2008. ">December 8, 2007, Philadelphia, Pa., USA - GlaxoSmithKline plc announced that Eddie Gray, senior vice president and general manager pharmaceuticals UK, will succeed Andrew Witty as president, pharmaceuticals Europe for GlaxoSmithKline, effective January 1, 2008. ">
December 8, 2007, Philadelphia, Pa., USA - GlaxoSmithKline plc announced that Eddie Gray, senior vice president and general manager pharmaceuticals UK, will succeed Andrew Witty as president, pharmaceuticals Europe for GlaxoSmithKline, effective January 1, 2008. ">
Philadelphia, Pa., USA - December 8, 2007, Philadelphia, Pa., USA - GlaxoSmithKline plc announced that Eddie Gray, senior vice president and general manager pharmaceuticals UK, will succeed Andrew Witty as president, pharmaceuticals Europe for GlaxoSmithKline, effective January 1, 2008.
Article continues below
Mr. Gray holds an honors degree in Chemistry and Management Studies from the University of London, and an MBA from the Cranfield School of Management in the UK.
Mr. Gray joined SmithKline Beecham in 1988 as National Sales Manager. He served at various positions in the UK company, including Head of Hospital Sales, Marketing Manager for Anti-Infective products and Business Unit Director for the UK Pharmaceuticals General Medicine.
After moving in the U.S., Mr. Gray assumed responsibility for Market Research for the US Pharmaceuticals business.
Mr. Gray became Vice President & Director of Anti-Infectives Marketing, then Vaccines Marketing in the US, before assuming his role in Canada.
Mr. Gray was appointed Senior Vice President and General Manager, Pharmaceuticals UK for GlaxoSmithKline in 2001. He is a member of the Pharmaceuticals Europe Executive Team.
Mr. Gray serves on the Board of Management of the Association of the British Pharmaceutical Industry (ABPI) and chairs the ABPI Economic Strategy Group. Mr. Gray is an advisory board member of Opportunity Now, and a Trustee of Project HOPE UK.
At the same time, Mr. Andrew Witty, CEO Designate, and Chris Viehbacher, President US Pharmaceuticals, have been appointed Executive Directors and will join the Board of the Company, effective January 31, 2008. ■
December 8, 2007, Philadelphia, Pa., USA - GlaxoSmithKline plc announced that Eddie Gray, senior vice president and general manager pharmaceuticals UK, will succeed Andrew Witty as president, pharmaceuticals Europe for GlaxoSmithKline, effective January 1, 2008.